glp 1 parkinson's disease and neuroprotection PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's models Neuroprotective effects of GLP-1 receptor

A consultation with our medical team is required to determine if this therapy is appropriate for you

The oldest citation is from 2007, and 93% of the references were published in the last 6 years (2018 to 2024)

As more people initiate GLP-1 RAs for diverse indications, understanding these nuanced experiences will be key to improving adherence, minimizing harm, and optimizing outcomes

W.KelleyK

Before recommending peptide therapy, our providers may evaluate: Your health goals Current symptoms Injury or recovery concerns Medical history Medication and supplement use Sleep, stress, and lifestyle factors Mental health history Hormonal or metabolic concerns Lab testing when appropriate Safety risks and contraindications If peptide therapy is appropriate, your provider will explain the recommended approach, possible benefits, limitations, risks, and follow-up plan